New efforts to develop the ultimate
vaccine for malaria elimination to prevent
P. falciparum and P. vivax malaria and reduce transmission of both parasites
UltiMalVax: to the next
generation malaria vaccine
Today's catalyst for tomorrow's vaccines
Since 1998, working with partners globally to develop safe, effective and affordable vaccines.
We are a science-driven organisation, leading innovative solutions for vaccine R&D through cross-cutting activities, capacity strengthening and advocacy. EVI supports vaccine R&D by taking action from three different areas:
Translational product development
Our goal is to catalyse the development of vaccines for global health. We actively engage in product development activities for new vaccine candidates and bridge early-stage vaccine candidates from discovery to early clinical trials.
We are committed to supporting vaccine development beyond individual vaccine candidates. We engage in initiatives aimed at creating harmonisation between stakeholders, promoting networking, developing innovative R&D solutions, and accessing vaccine infrastructure at the European and global level.
Knowledge sharing & advocacy
Our goal is to extend the benefits of vaccines to all people by improving knowledge access and uptake of vaccines.
We take active part in vaccine advocacy, and supply data and road maps that can enable decision makers to make evidence-based decisions on vaccines and immunisation.